Authors:
PAZDUR R
LASSERE Y
DIAZCANTON E
BREADY B
HO DH
Citation: R. Pazdur et al., PHASE-I TRIAL OF URACIL-TEGAFUR (UFT) PLUS ORAL LEUCOVORIN - 14-DAY SCHEDULE, Investigational new drugs, 15(2), 1997, pp. 123-128
Authors:
PAZDUR R
LASSERE Y
DIAZCANTON E
BREADY B
HO DH
Citation: R. Pazdur et al., PHASE-I TRIALS OF URACIL-TEGAFUR (UFT) USING 5 AND 28 DAY ADMINISTRATION SCHEDULES - DEMONSTRATION OF SCHEDULE-DEPENDENT TOXICITIES, Anti-cancer drugs, 7(7), 1996, pp. 728-733
Authors:
MOORE DF
PAZDUR R
SUGARMAN S
JONES D
LIPPMAN SM
BREADY B
ABBRUZZESE JL
Citation: Df. Moore et al., PILOT PHASE-II TRIAL OF 13-CIS-RETINOIC ACID AND INTERFERON-ALPHA COMBINATION THERAPY FOR ADVANCED PANCREATIC ADENOCARCINOMA, American journal of clinical oncology, 18(6), 1995, pp. 525-527
Authors:
PAZDUR R
BREADY B
AJANI JA
ABBRUZZESE JL
MARKOWITZ A
SUGARMAN S
JONES D
LEVIN B
Citation: R. Pazdur et al., PHASE-II TRIAL OF ISOTRETINOIN AND RECOMBINANT INTERFERON ALFA-2A IN METASTATIC COLORECTAL-CARCINOMA, American journal of clinical oncology, 18(5), 1995, pp. 436-438
Authors:
PAZDUR R
MOORE DF
BREADY B
GIANNONE L
MALDONADO A
LIN YG
FUEGER RH
WINN RJ
LEVIN B
Citation: R. Pazdur et al., PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA, Annals of oncology, 5(7), 1994, pp. 646-648
Authors:
MOORE DF
PAZDUR R
ABBRUZZESE JL
AJANI JA
DUBOVSKY DW
WADE JL
BELT RJ
MANGOLD C
BREADY B
WINN RJ
Citation: Df. Moore et al., PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA, Annals of oncology, 5(3), 1994, pp. 286-287
Authors:
PAZDUR R
LASSERE Y
RHODES V
AJANI JA
SUGARMAN SM
PATT YZ
JONES DV
MARKOWITZ AB
ABBRUZZESE JL
BREADY B
LEVIN B
Citation: R. Pazdur et al., PHASE-II TRIAL OF URACIL AND TEGAFUR PLUS ORAL LEUCOVORIN - AN EFFECTIVE ORAL REGIMEN IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 12(11), 1994, pp. 2296-2300